Skip to content

Biotech Stocks

Ultra Risk Could Lead To Ultra Riches With These 3 Biotech Stocks

When it comes to the three clinical-stage biotech stocks highlighted in today’s article, the author declares that, while they are all “relatively small at the moment…they have potential blockbuster drugs in development that could send their stock prices screaming higher.” For these three biotech stocks whose ultra risk could lead to ultra riches with clinical trial success, CLICK HERE.

3 Market-Beating Biotech Stocks With More Room To Run – Including One “Oddball” Pick

Biotech stocks have weathered the coronavirus selloff pretty well on the whole – and today’s article notes that “Several biotechs have delivered solid gains in the midst of the overall stock market plunge.” For three top biotech stock picks that have been beating the market and that still have lots of room to run from here – including one “oddball”… 

CLICK HERE »3 Market-Beating Biotech Stocks With More Room To Run – Including One “Oddball” Pick